Aspirin may help prevent serious liver disease including cancer, a new study has found. According to the results of this study, which was by the National Cancer Institute in Rockville, Md., aspirin users are 41 percent less likely to develop liver cancer and 45 percent less likely to die from chronic liver disease than non-users.
"These associations are prominent with the use of aspirin, and if confirmed, might open new vistas for chemoprevention of hepatocellular carcinoma and chronic liver disease," the study's author Vikrant Sahasrabuddhe wrote in the December 5 issue of the Journal of the National Cancer Institute.
More than 300,000 people aged 50 to 71 were followed for a period of up to 10 to 12 years for this study. During that time, more than 400 participants died from chronic liver disease and 250 were diagnosed with liver cancer.
The study also found that people who took non-aspirin nonsteroidal anti-inflammatory drugs were 26 percent less likely to die from chronic liver disease but no less likely to be diagnosed with liver cancer.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org